Olivia Sgarbura

Olivia Sgarbura


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
FPFlorian Primavesi
Florian Primavesi
Manuel MaglioneManuel Maglione
Manuel Maglione
FCFederica Cipriani
Federica Cipriani
TDTimm Denecke
Timm Denecke
COChristian Eugen Oberkofler
Christian Eugen Oberkofler
SSStefan Stättner
Stefan Stättner
Background: Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus guidelines provide guidance for preoperative patient assessment. Methods: A modified Delphi approach was used to achieve consensus. The expert panel consisted of hepatobiliary surgeons, radiologists, nuclear medicine specialists, and hepatologists. The guideline process was supervised by a methodologist and reviewed by a patient representative. A systematic literature search was performed in PubMed/MEDLINE, the Cochrane library, and the WHO International Clinical Trials Registry. Evidence assessment and statement development followed Scottish Intercollegiate Guidelines Network methodology. Results: Based on 271 publications covering 4 key areas, 21 statements (at least 85 per cent agreement) were produced (median level of evidence 2− to 2+). Only a few systematic reviews (2++) and one RCT (1+) were identified. Preoperative liver function assessment should be considered before complex resections, and in patients with suspected or known underlying liver disease, or chemotherapy-associated or drug-induced liver injury. Clinical assessment and blood-based scores reflecting liver function or portal hypertension (for example albumin/bilirubin, platelet count) aid in identifying risk of PHLF. Volumetry of the future liver remnant represents the foundation for assessment, and can be combined with indocyanine green clearance or LiMAx® according to local expertise and availability. Functional MRI and liver scintigraphy are alternatives, combining FLR volume and function in one examination. Conclusion: These guidelines reflect established methods to assess preoperative liver function and PHLF risk, and have uncovered evidence gaps of interest for future research.

1 December 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
OSOlivia Sgarbura
Olivia Sgarbura
MHMartin Hübner
Martin Hübner
MAMohammad Alyami
Mohammad Alyami
CEClarisse Eveno
Clarisse Eveno
JGJohan Gagnière
Johan Gagnière
FQFrançois Quénet
François Quénet

1 March 2022 in Pleura and Peritoneum
Verified
Journal Article
Open access
PDF file
OSOlivia Sgarbura
Olivia Sgarbura
CEClarisse Eveno
Clarisse Eveno
MAMohammad Alyami
Mohammad Alyami
NBNaoual Bakrin
Naoual Bakrin
DGDelia Cortes Guiral
Delia Cortes Guiral
MHMartin Hübner
Martin Hübner
Objectives: Safe implementation and thorough evaluation of new treatments require prospective data monitoring and standardization of treatments. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a promising alternative for the treatment of patients with peritoneal disease with an increasing number of suggested drug regimens. The aim was to reach expert consensus on current PIPAC treatment protocols and to define the most important research topics. Methods: The expert panel included the most active PIPAC centers, organizers of PIPAC courses and principal investigators of prospective studies on PIPAC. A comprehensive literature review served as base for a two-day hybrid consensus meeting which was accompanied by a modified three-round Delphi process. Consensus bar was set at 70% for combined (strong and weak) positive or negative votes according to GRADE. Research questions were prioritized from 0 to 10 (highest importance). Results: Twenty-two out of 26 invited experts completed the entire consensus process. Consensus was reached for 10/10 final questions. The combination of doxorubicin (2.1 mg/m 2 ) and cisplatin (10.5 mg/m 2 ) was endorsed by 20/22 experts (90.9%). 16/22 (72.7%) supported oxaliplatin at 120 with potential reduction to 90 mg/m 2 (frail patients), and 77.2% suggested PIPAC-Ox in combination with 5-FU. Mitomycin-C and Nab-paclitaxel were favoured as alternative regimens. The most important research questions concerned PIPAC conditions (n=3), standard (n=4) and alternative regimens (n=5) and efficacy of PIPAC treatment (n=2); 8/14 were given a priority of ≥8/10. Conclusions: The current consensus should help to limit heterogeneity of treatment protocols but underlines the utmost importance of further research.

1 January 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
OSOlivia Sgarbura
Olivia Sgarbura
LVLAURENT VILLENEUVE
LAURENT VILLENEUVE
MAMohammad Alyami
Mohammad Alyami
NBNaoual Bakrin
Naoual Bakrin
JTJuan José Torrent
Juan José Torrent
WWWouter Willaert
Wouter Willaert

1 April 2022 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Martin HubnerMartin Hubner
Martin Hubner
MAMohammad Alyami
Mohammad Alyami
LVLAURENT VILLENEUVE
LAURENT VILLENEUVE
DCDelia Cortés-Guiral
Delia Cortés-Guiral
MNMaciej Nowacki
Maciej Nowacki
WWWouter Willaert
Wouter Willaert

1 December 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
MAMohammad Alyami
Mohammad Alyami
OSOlivia Sgarbura
Olivia Sgarbura
VKVladimir Khomyakov
Vladimir Khomyakov
PHPhilipp Horvath
Philipp Horvath
GVGiuseppe Vizzielli
Giuseppe Vizzielli
MHMartin Hübner
Martin Hübner